Charles River Laboratories | Értékesítés



Sales változás Dátum
Agilent USD 1.68B 20M 2025-01
Align Technology USD 995.22M 17.35M 2024-12
Bio-Rad Laboratories USD 667.5M 17.8M 2024-12
Bruker USD 979.6M 115.2M 2024-12
Cardinal Health USD 55.26B 2.99B 2024-12
Charles River Laboratories USD 1B 7.21M 2024-12
Cigna USD 65.65B 1.95B 2024-12
CVS Health USD 97.71B 2.28B 2024-12
Danaher USD 6.54B 740M 2024-12
Dentsply International USD 905M 46M 2024-12
Elevance Health 45B 300M 2024-12
Galapagos EUR 75.85M 16M 2024-12
Hologic USD 1.02B 33.9M 2024-12
Humana USD 29.2B 101M 2024-12
Illumina USD 1.1B 24M 2024-12
Incyte USD 1.18B 40.83M 2024-12
IQVIA Holdings USD 3.96B 62M 2024-12
Laboratory Of America USD 3.33B 47.4M 2024-12
Lonza CHF 3.52B 460M 2024-12
McKesson USD 95.29B 1.64B 2024-12
Merck EUR 5.42B 152M 2024-12
Mettler Toledo International USD 1.05B 95.46M 2024-12
Novartis USD 13.15B 330M 2024-12
Pfizer USD 17.76B 61M 2024-12
Quest Diagnostics USD 2.62B 130M 2024-12
Revvity USD 729.37M 45.32M 2024-12
Thermo Fisher Scientific USD 11.4B 797M 2024-12
United Therapeutics USD 735.9M 13M 2024-12
UnitedHealth 100.81B 13M 2024-12
Walgreens Boots Alliance USD 39.46B 1.91B 2024-11
Waters USD 872.71M 132.41M 2024-12
West Pharmaceutical Services USD 748.8M 1.9M 2024-12



Charles River Laboratories Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.